Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
Corcoran, A.T.; Gingrich, J.R.
Oncology 24(12): 1161; 1166
2010
ISSN/ISBN: 0890-9091 PMID: 21141699 Document Number: 640256
Document emailed within 1 workday
Related Documents
Baselli, E.C.; Greenberg, R.E. 2000: Intravesical therapy for superficial bladder cancer Oncology 14(5): 719Badalament, R.A.; Ortolano, V.; Burgers, J.K. 1992: Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy Urologic Clinics of North America 19(3): 485-498
Cao, M.; Ma, C.-k.; Ma, J.; Chen, H.-g.; Xue, W. 2011: Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer Zhonghua Zhong Liu Za Zhi 33(5): 385-387
Mauroy, B.; Bonnal, J.L.; Prevost, B.; Chive, M.; Lhotellier, V.; Sozanski, J.P.; Vanseymortier, L.; Stefaniak, X. 1999: Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(1): 69-80
Chen, S.; Lin, Z.; Ye, C.; Xu, E. 1996: Long-term results of intravesical N-CWS therapy for preventing bladder cancer recurrence after operation Chinese Medical Journal 109(11): 890-891
Punga-Maole, M.L.; Hubert, J.; Mangin, P. 1995: Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
Von Ardenne, M.; Reitnauer, P.G. 1971: In vitro study for shortening of hyperthermia duration in multi-step cancer therapy. Release of lysosomal cytolysis chain reaction by over-acidification and hyperthermia and its continuation after cessation of hyperthermia Archiv für Geschwulstforschung 38(3): 264-269
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Whelan, D.P. 2008: Words of wisdom. Re: predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the Surveillance, Epidemiology and End Results Programme (SEER) 2003 Patterns of Care Project European Urology 54(6): 1443-1444
Kinoshita, N.; Tochigi, H.; Yanagawa, M.; Yamakawa, K.; Sakurai, M.; Hioki, T.; Kawamura, J. 1990: Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside Hinyokika Kiyo. Acta Urologica Japonica 36(3): 257-263
Steg, A.; Belas, M.; Leleu, C.; Boccon-Gibod, L. 1989: Intravesical BCG therapy in patients with superficial bladder tumors Progress in Clinical and Biological Research 310(11): 153-160
Iemura, Y.; Fukui, S.; Matsumura, Y.; Kagebayashi, Y.; Toyoshima, Y.; Inoue, T.; Samma, S. 2018: Bladder Rupture during Intravesical BCG Therapy : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(1): 25-28
Lamm, D.L.; McGee, W.R.; Hale, K. 2005: Bladder cancer: current optimal intravesical treatment Urologic Nursing 25(5): 323-326; 331-332
Xerri, B.; Chrétien, Y.; Le Parc, J.M. 1993: Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder European Journal of Medicine 2(8): 503-505
Van der Meijden, A.P. 1992: New approaches to intravesical chemo-immunotherapy in superficial bladder cancer Progress in Clinical and Biological Research 378: 95-101
Moriyama, M.; Kubota, Y.; Miura, T.; Shuin, T.; Noguchi, S. 1983: The effect of intravesical chemotherapy on superficial urinary bladder cancer Hinyokika Kiyo. Acta Urologica Japonica 29(3): 351-355
Segawa, N.; Inamoto, T.; Nomi, H.; Ibuki, N.; Azuma, H.; Katsuoka, Y. 2009: Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer Hinyokika Kiyo. Acta Urologica Japonica 55(4): 175-180
Schreinemachers, L.; Van der Meyden, A.; Steerenberg, P.; Feitz, W.; Groothuis, D.; De Jong, W.; Debruyne, F. 1987: BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 713-716
Tubaro, A.; Stoppacciaro, A.; Velotti, F.; Bossola, P.C.; Cusumano, G.; Vicentini, C.; De Carli, P.; Ruco, L.; Santoni, A.; Cancrini, A. 1995: Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2 European Urology 28(4): 297-303
Maffezzini, M.; Simonato, A.; Lodolo, C.; Raber, M.; Carmignani, G. 1995: Short schedule intravesical mitomycin preceding transurethral resection for recurrent Ta-T1, G1-G2 bladder cancer Tumori 81(3): 191-193